Antitumor Activity of a Novel Quinoline Derivative, TAS‐103, with Inhibitory Effects on Topoisomerases I and II

Ítems similars

• In vitro Antitumor Activity of TAS‐103, a Novel Quinoline Derivative That Targets Topoisomerases I and II
  per: Aoyagi, Yoshimi, et al.
  Publicat: (1999)
• Establishment and Characterization of 6‐[[2‐(Dimethylamino)ethyl]amino]‐3‐hydroxy‐7H‐indeno[2,1‐c]quinolin‐7‐one dihydrochloride (TAS‐103)‐resistant Cell Lines
  per: Aoyagi, Yoshimi, et al.
  Publicat: (2000)
• A Dual Topoisomerase Inhibitor, TAS‐103, Induces Apoptosis in Human Cancer Cells
  per: Ohyama, Tomoko, et al.
  Publicat: (1999)
• A Potential Use of a Synthetic Retinoid TAC‐101 as an Orally Active Agent That Blocks Angiogenesis in Liver Metastases of Human Stomach Cancer Cells
  per: Oikawa, Tsutomu, et al.
  Publicat: (2001)
• Antitumor activities of selective HSP90α/β inhibitor, TAS-116, in combination with bortezomib in multiple myeloma
  per: Suzuki, Rikio, et al.
  Publicat: (2014)